SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001062993-22-021832
Filing Date
2022-11-10
Accepted
2022-11-10 16:01:12
Documents
76
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q form10q.htm   iXBRL 10-Q 1009879
2 EXHIBIT 31.1 exhibit31-1.htm EX-31.1 5136
3 EXHIBIT 31.2 exhibit31-2.htm EX-31.2 5037
4 EXHIBIT 32.1 exhibit32-1.htm EX-32.1 3026
5 EXHIBIT 32.2 exhibit32-2.htm EX-32.2 3159
  Complete submission text file 0001062993-22-021832.txt   5924464

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT igxt-20220930.xsd EX-101.SCH 79577
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT igxt-20220930_cal.xml EX-101.CAL 38775
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT igxt-20220930_def.xml EX-101.DEF 177378
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT igxt-20220930_lab.xml EX-101.LAB 873270
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT igxt-20220930_pre.xml EX-101.PRE 320268
70 EXTRACTED XBRL INSTANCE DOCUMENT form10q_htm.xml XML 770798
Mailing Address 6420 ABRAMS SAINT LAURENT A8 H4S 1Y2
Business Address 6420 ABRAMS SAINT LAURENT A8 H4S 1Y2 514-331-7440
IntelGenx Technologies Corp. (Filer) CIK: 0001098880 (see all company filings)

IRS No.: 870638336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-31187 | Film No.: 221376880
SIC: 2834 Pharmaceutical Preparations